Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

A new MTX2 gene mutation caused a severe genetic disorder in a young Chinese girl.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

New alopecia treatments aim for better results and fewer side effects.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

AGEs may cause hair loss by increasing inflammation in hair follicles.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.

Most children with skin inflammation taking methotrexate had lab abnormalities, but liver issues often improved without changing the medication dose.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

CO₂ laser treatment is fast and effective for some benign skin tumors with minimal side effects.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Some cancer treatments can cause permanent hair loss.